AAAAAA

   
Results: 1-16 |
Results: 16

Authors: Broocks, A Meyer, T Gleiter, CH Hillmer-Vogel, U George, A Bartmann, U Bandelow, B
Citation: A. Broocks et al., Effect of aerobic exercise on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine and to ipsapirone in untrained healthy subjects, PSYCHOPHAR, 155(3), 2001, pp. 234-241

Authors: Doering, S Wedekind, D Pilz, J Bandelow, B Adler, L Huether, G
Citation: S. Doering et al., Cortisol in night-urine: Introduction of a research method in psychoneuroendocrinology, Z PSYCHOS M, 47(1), 2001, pp. 42-57

Authors: Heindl, S Binder, C Desel, H Matthies, U Lojewski, I Bandelow, B Kahl, GF Chemnitius, JM
Citation: S. Heindl et al., Confusion and excitability of initially undetermined cause in the course of poisoning with deadly nightshade in attempted suicide: symptoms, differential diagnosis, toxicology and physostigmine treatment of an anticholinergic syndrome, DEUT MED WO, 125(45), 2000, pp. 1361-1365

Authors: Bleich, S Degner, D Bandelow, B von Ahsen, N Ruther, E Kornhuber, J
Citation: S. Bleich et al., Plasma homocysteine is a predictor of alcohol withdrawal seizures, NEUROREPORT, 11(12), 2000, pp. 2749-2752

Authors: Broocks, A Junghanns, K Thiel, A Gleiter, CH Bandelow, B
Citation: A. Broocks et al., Advances in the pharmacotherapy of depression by new antidepressants, F NEUR PSYC, 68(1), 2000, pp. 17-24

Authors: Wedekind, D Bandelow, B Broocks, A Hajak, G Ruther, E
Citation: D. Wedekind et al., Salivary, total plasma and plasma free cortisol in panic disorder, J NEURAL TR, 107(7), 2000, pp. 831-837

Authors: Pauls, J Bandelow, B Ruther, E Kornhuber, J
Citation: J. Pauls et al., Polymorphism of the gene of angiotensin converting enzyme: lack of association with mood disorder, J NEURAL TR, 107(11), 2000, pp. 1361-1366

Authors: Broocks, A Bandelow, B George, A Jestrabeck, C Opitz, M Bartmann, U Gleiter, CH Meineke, I Roed, IS Ruther, E Hajak, G
Citation: A. Broocks et al., Increased psychological responses and divergent neuroendocrine responses to m-CPP and ipsapirone in patients with panic disorder, INT CLIN PS, 15(3), 2000, pp. 153-161

Authors: Bandelow, B Broocks, A Pekrun, G George, A Meyer, T Pralle, L Bartmann, U Hillmer-Vogel, U Ruther, E
Citation: B. Bandelow et al., The Use of the Panic and Agoraphobia Scale (P & A) in a controlled clinical trial, PHARMACOPS, 33(5), 2000, pp. 174-181

Authors: Bandelow, B Wedekind, D Sandvoss, V Broocks, A Hajak, G Pauls, J Peter, H Ruther, E
Citation: B. Bandelow et al., Diurnal variation of cortisol in panic disorder, PSYCHIAT R, 95(3), 2000, pp. 245-250

Authors: Degner, D Bleich, S Grohmann, R Bandelow, B Ruther, E
Citation: D. Degner et al., Myocarditis associated with clozapine treatment, AUST NZ J P, 34(5), 2000, pp. 880-880

Authors: Bandelow, B Wedekind, D Pauls, J Broocks, A Hajak, G Ruther, E
Citation: B. Bandelow et al., Salivary cortisol in panic attacks, AM J PSYCHI, 157(3), 2000, pp. 454-456

Authors: Bandelow, B Brunner, E Beinroth, D Pralle, L Broocks, A Hajak, G Ruther, E
Citation: B. Bandelow et al., Application of a new statistical approach to evaluate a clinical trial with panic disorder patients, EUR ARCH PS, 249(1), 1999, pp. 21-27

Authors: Broocks, A Meyer, T George, A Hillmer-Vogel, U Meyer, D Bandelow, B Hajak, G Bartmann, U Gleiter, CH Ruther, E
Citation: A. Broocks et al., Decreased neuroendocrine responses to meta-chlorophenylpiperazine (m-CPP) but normal responses to ipsapirone in marathon runners, NEUROPSYCH, 20(2), 1999, pp. 150-161

Authors: Broocks, A Bandelow, B
Citation: A. Broocks et B. Bandelow, Fetal alcohol exposure and adult psychiatric disorders - Dr. Broocks and Bandelow reply, AM J PSYCHI, 156(7), 1999, pp. 1129-1130

Authors: Munzel, U Bandelow, B
Citation: U. Munzel et B. Bandelow, The use of parametric vs. nonparametric tests in the statistical evaluation of rating scales, PHARMACOPS, 31(6), 1998, pp. 222-224
Risultati: 1-16 |